German fragrances maker Symrise AG said on Monday it is in advanced talks to sell its terpenes business and that it would take a non-cash impairment of about 145 million euros ($169.22 million) related to the sale in the fourth quarter.
Germany's Symrise says potential unit sale, Swedencare impairment to hurt earnings
